Mitsubishi UFJ Asset Management Co., Ltd. - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
Mitsubishi UFJ Asset Management Co., Ltd. ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$104,325
-41.8%
127,226
+7.8%
0.00%
Q4 2022$179,360
-18.8%
118,000
-7.8%
0.00%
-100.0%
Q3 2022$221,000
+0.9%
128,049
+1.2%
0.00%0.0%
Q2 2022$219,000
+36.0%
126,500
+182.1%
0.00%0.0%
Q1 2022$161,000
-22.6%
44,845
+12.3%
0.00%0.0%
Q4 2021$208,000
-35.6%
39,948
-11.4%
0.00%
-50.0%
Q3 2021$323,000
-22.7%
45,0670.0%0.00%0.0%
Q2 2021$418,000
+40.3%
45,067
+40.5%
0.00%0.0%
Q1 2021$298,000
+53.6%
32,073
+46.3%
0.00%0.0%
Q4 2020$194,000
+26.0%
21,919
+64.9%
0.00%
+100.0%
Q3 2020$154,000
-56.6%
13,296
+1.1%
0.00%
-75.0%
Q2 2020$355,000
+327.7%
13,155
-67.5%
0.00%
+300.0%
Q3 2019$83,000
-19.4%
40,478
+15.0%
0.00%
-50.0%
Q2 2019$103,000
-12.7%
35,193
+11.7%
0.00%0.0%
Q1 2019$118,000
-4.1%
31,514
+9.3%
0.00%
-33.3%
Q4 2018$123,000
-16.9%
28,837
+8.4%
0.00%0.0%
Q3 2018$148,00026,6040.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Green Alpha Advisors, LLC 570,049$221,7490.17%
GMT CAPITAL CORP 1,513,500$588,7520.02%
Cedar Brook Financial Partners, LLC 130,522$50,7730.01%
Arlington Capital Management, Inc. 27,735$10,7890.01%
GSA CAPITAL PARTNERS LLP 296,948$1160.01%
Keystone Financial Group 109,897$42,7510.01%
Hennion & Walsh Asset Management, Inc. 163,562$63,6260.00%
Freedom Investment Management, Inc. 62,298$24,2340.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,149,974$447,3400.00%
Renaissance Technologies 4,889,500$1,9020.00%
View complete list of INOVIO PHARMACEUTICALS INC shareholders